These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8288571)

  • 1. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
    Mizuno K; Inoue H; Hagiya M; Shimizu S; Nose T; Shimohigashi Y; Nakamura T
    J Biol Chem; 1994 Jan; 269(2):1131-6. PubMed ID: 8288571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains.
    Holmes O; Pillozzi S; Deakin JA; Carafoli F; Kemp L; Butler PJ; Lyon M; Gherardi E
    J Mol Biol; 2007 Mar; 367(2):395-408. PubMed ID: 17258232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor.
    Lokker NA; Presta LG; Godowski PJ
    Protein Eng; 1994 Jul; 7(7):895-903. PubMed ID: 7971951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
    Sakata H; Stahl SJ; Taylor WG; Rosenberg JM; Sakaguchi K; Wingfield PT; Rubin JS
    J Biol Chem; 1997 Apr; 272(14):9457-63. PubMed ID: 9083085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.
    Ultsch M; Lokker NA; Godowski PJ; de Vos AM
    Structure; 1998 Nov; 6(11):1383-93. PubMed ID: 9817840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo.
    Hartmann G; Prospero T; Brinkmann V; Ozcelik C; Winter G; Hepple J; Batley S; Bladt F; Sachs M; Birchmeier C; Birchmeier W; Gherardi E
    Curr Biol; 1998 Jan; 8(3):125-34. PubMed ID: 9443912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
    Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
    Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
    Lietha D; Chirgadze DY; Mulloy B; Blundell TL; Gherardi E
    EMBO J; 2001 Oct; 20(20):5543-55. PubMed ID: 11597998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation.
    Chirgadze DY; Hepple J; Byrd RA; Sowdhamini R; Blundell TL; Gherardi E
    FEBS Lett; 1998 Jun; 430(1-2):126-9. PubMed ID: 9678607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
    Rubin JS; Day RM; Breckenridge D; Atabey N; Taylor WG; Stahl SJ; Wingfield PT; Kaufman JD; Schwall R; Bottaro DP
    J Biol Chem; 2001 Aug; 276(35):32977-83. PubMed ID: 11435444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain structure of hepatocyte growth factor/scatter factor (HGF/SF).
    Gherardi E; Hartmann G; Hepple J; Chirgadze D; Srinivasan N; Blundell T
    Ciba Found Symp; 1997; 212():84-93; discussion 93-104. PubMed ID: 9524765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of heparin-binding stretches of a naturally occurring deleted variant of hepatocyte growth factor (dHGF).
    Kinosaki M; Yamaguchi K; Murakami A; Ueda M; Morinaga T; Higashio K
    Biochim Biophys Acta; 1998 Apr; 1384(1):93-102. PubMed ID: 9602078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site.
    Zhou H; Mazzulla MJ; Kaufman JD; Stahl SJ; Wingfield PT; Rubin JS; Bottaro DP; Byrd RA
    Structure; 1998 Jan; 6(1):109-16. PubMed ID: 9493272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of human hepatocyte growth factor mutants obtained by deletion of structural domains.
    Okigaki M; Komada M; Uehara Y; Miyazawa K; Kitamura N
    Biochemistry; 1992 Oct; 31(40):9555-61. PubMed ID: 1327117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and conformational analysis of fragment peptide corresponding to the heparin-binding site of hepatocyte growth factor.
    Aoyama H; Naka D; Yoshiyama Y; Ishii T; Kondo J; Mitsuka M; Hayase T
    Biochemistry; 1997 Aug; 36(33):10286-91. PubMed ID: 9254627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for agonism and antagonism of hepatocyte growth factor.
    Tolbert WD; Daugherty-Holtrop J; Gherardi E; Vande Woude G; Xu HE
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13264-9. PubMed ID: 20624990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of kringle domains or the N-terminal hairpin structure in hepatocyte growth factor results in marked decreases in related biological activities.
    Matsumoto K; Takehara T; Inoue H; Hagiya M; Shimizu S; Nakamura T
    Biochem Biophys Res Commun; 1991 Dec; 181(2):691-9. PubMed ID: 1661588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
    Hartmann G; Naldini L; Weidner KM; Sachs M; Vigna E; Comoglio PM; Birchmeier W
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11574-8. PubMed ID: 1280830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor.
    Merkulova-Rainon T; England P; Ding S; Demerens C; Tobelem G
    J Biol Chem; 2003 Sep; 278(39):37400-8. PubMed ID: 12847110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants.
    Lyon M; Deakin JA; Mizuno K; Nakamura T; Gallagher JT
    J Biol Chem; 1994 Apr; 269(15):11216-23. PubMed ID: 8157651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.